RMH（8437）2025年12月31日宣布，与独立第三方买方订立买卖协议，将以1港元的对价出售其直接全资附属公司德斯（香港）控股有限公司全部已发行股份。完成后，目标公司将不再纳入集团综合财务报表。
根据公告，截至2025年10月31日，目标集团未审核负债净额约为2,209,000新加坡元。根据买卖协议，集团将豁免目标公司欠付的内部集团间款项，也将不再持有目标公司股权。
目标集团主要从事医美服务和护肤品销售。公告显示，买方是一位拥有10年以上经验的商人，且与RMH及其关连人士并无关系。RMH预计可录得约2,209,000新加坡元的收益（尚待最终审核），拟将所得款项用于一般营运资金。
董事会指出，此次出售将有助于精简业务运营、减少负债及降低资产负债率，从而集中资源发展核心业务。由于此次交易的适用百分比率介于5%至25%之间，根据GEM上市规则，这笔交易被界定为须予披露的交易。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.